A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults
Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age